Annual Total Liabilities
$69.43 M
+$48.16 M+226.36%
December 31, 2024
Summary
- As of March 12, 2025, PTGX annual total liabilities is $69.43 million, with the most recent change of +$48.16 million (+226.36%) on December 31, 2024.
- During the last 3 years, PTGX annual total liabilities has risen by +$21.76 million (+45.63%).
- PTGX annual total liabilities is now -7.37% below its all-time high of $74.95 million, reached on December 31, 2019.
Performance
PTGX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$69.43 M
-$2.51 M-3.49%
December 31, 2024
Summary
- As of March 12, 2025, PTGX quarterly total liabilities is $69.43 million, with the most recent change of -$2.51 million (-3.49%) on December 31, 2024.
- Over the past year, PTGX quarterly total liabilities has dropped by -$2.51 million (-3.49%).
- PTGX quarterly total liabilities is now -7.37% below its all-time high of $74.95 million, reached on December 31, 2019.
Performance
PTGX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PTGX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +226.4% | -3.5% |
| 3 y3 years | +45.6% | -3.5% |
| 5 y5 years | -7.4% | -3.5% |
PTGX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +226.4% | -5.3% | +226.4% |
| 5 y | 5-year | -7.4% | +226.4% | -7.4% | +226.4% |
| alltime | all time | -7.4% | +2825.8% | -7.4% | +1589.3% |
Protagonist Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $69.43 M(+226.4%) | $69.43 M(-3.5%) |
| Sep 2024 | - | $71.94 M(-1.9%) |
| Jun 2024 | - | $73.31 M(+6.5%) |
| Mar 2024 | - | $68.83 M(+223.5%) |
| Dec 2023 | $21.27 M(-34.2%) | $21.27 M(-23.7%) |
| Sep 2023 | - | $27.87 M(+5.6%) |
| Jun 2023 | - | $26.40 M(+11.4%) |
| Mar 2023 | - | $23.69 M(-26.7%) |
| Dec 2022 | $32.32 M(-32.2%) | $32.32 M(-16.2%) |
| Sep 2022 | - | $38.56 M(-9.3%) |
| Jun 2022 | - | $42.53 M(-8.6%) |
| Mar 2022 | - | $46.52 M(-2.4%) |
| Dec 2021 | $47.67 M(+6.3%) | $47.67 M(+9.6%) |
| Sep 2021 | - | $43.52 M(-7.0%) |
| Jun 2021 | - | $46.78 M(+20.8%) |
| Mar 2021 | - | $38.74 M(-13.7%) |
| Dec 2020 | $44.86 M | $44.86 M(-6.0%) |
| Sep 2020 | - | $47.73 M(-17.0%) |
| Jun 2020 | - | $57.49 M(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $72.23 M(-3.6%) |
| Dec 2019 | $74.95 M(+178.0%) | $74.95 M(+26.5%) |
| Sep 2019 | - | $59.27 M(-7.1%) |
| Jun 2019 | - | $63.79 M(+103.0%) |
| Mar 2019 | - | $31.42 M(+16.6%) |
| Dec 2018 | $26.96 M(-37.5%) | $26.96 M(+8.3%) |
| Sep 2018 | - | $24.90 M(-16.5%) |
| Jun 2018 | - | $29.81 M(-13.9%) |
| Mar 2018 | - | $34.62 M(-19.7%) |
| Dec 2017 | $43.10 M(+569.8%) | $43.10 M(-18.0%) |
| Sep 2017 | - | $52.58 M(+456.5%) |
| Jun 2017 | - | $9.45 M(+21.5%) |
| Mar 2017 | - | $7.78 M(+20.9%) |
| Dec 2016 | $6.43 M(+22.6%) | $6.43 M(+20.3%) |
| Sep 2016 | - | $5.35 M(+30.1%) |
| Jun 2016 | - | $4.11 M(-24.9%) |
| Mar 2016 | - | $5.47 M(+4.3%) |
| Dec 2015 | $5.25 M(+121.2%) | $5.25 M |
| Dec 2014 | $2.37 M | - |
FAQ
- What is Protagonist Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual total liabilities year-on-year change?
- What is Protagonist Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly total liabilities year-on-year change?
What is Protagonist Therapeutics annual total liabilities?
The current annual total liabilities of PTGX is $69.43 M
What is the all time high annual total liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual total liabilities is $74.95 M
What is Protagonist Therapeutics annual total liabilities year-on-year change?
Over the past year, PTGX annual total liabilities has changed by +$48.16 M (+226.36%)
What is Protagonist Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PTGX is $69.43 M
What is the all time high quarterly total liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly total liabilities is $74.95 M
What is Protagonist Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PTGX quarterly total liabilities has changed by -$2.51 M (-3.49%)